Retrospective cohort study of Methotrexate use in the treatment of pediatric Crohn's disease

Inflammatory Bowel Diseases

Volumn 20, Issue 8, 2014, Pages 1341-1345

  Sunseri, Whitney ^a   Hyams, Jeffrey S ^b   Lerer, Trudy ^b   Mack, David R ^c   Griffiths, Anne M ^d   Otley, Anthony R ^e   Rosh, Joel R ^f   Carvalho, Ryan ^g   Grossman, Andrew B ^h   Cabrera, Jose ⁱ   Pfefferkorn, Marian D ^j   Rick, James ^k   Leleiko, Neal S ^l   Hitch, Meredith C ^m   Oliva Hemker, Maria ⁿ   Saeed, Shehzad A ^o   Kappelman, Michael ^p   Markowitz, James ^q   Keljo, David J ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^b Division of Pediatric Infectious Diseases   (United States)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

^e IWK HEALTH CENTRE   (Canada)

^f Goryeb Children's Hospital   (United States)

^g NATIONWIDE CHILDREN S HOSPITAL   (United States)

^h CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

ⁱ MEDICAL COLLEGE OF WISCONSIN   (United States)

^j RILEY HOSPITAL FOR CHILDREN   (United States)

^k Department of Gastroenterology Dayton Children's ^*  (United States)

^l HASBRO CHILDREN'S HOSPITAL   (United States)

^m Department of Radiology   (United States)

ⁿ JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^p UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^q Northwell Health   (United States)

more..

Author keywords

Crohn's disease; Hepatosplenic T cell lymphoma; Inflammatory bowel disease; Methotrexate; Pediatrics

Indexed keywords

ALANINE AMINOTRANSFERASE; METHOTREXATE; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALOPECIA; ARTICLE; CHILD; CHILDHOOD DISEASE; COHORT ANALYSIS; CROHN DISEASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG USE; DRUG WITHDRAWAL; DYSPNEA; FATIGUE; FEMALE; FOLLOW UP; HUMAN; IMMUNOMODULATION; LEUKOCYTE COUNT; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER; REMISSION; VOMITING; CLINICAL TRIAL; INFANT; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME; TREATMENT OUTCOME;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; MALE; METHOTREXATE; PROSPECTIVE STUDIES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84905463638     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0000000000000102     Document Type: Article

References (21)

1. Kugathasan S, Judd RH, Hoffmann RG, et al. Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. J Pediatr. 2003;143:525-531.
2. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000;119:895-902.
3. Sandhu BK, Fell JM, Beattie RM, et al. Guidelines for the management of inflammatory bowel disease in children in the United Kingdom. J Pediatr Gastroenterol Nutr. 2010;50(suppl 1):S1-S13.
4. Rosh JR, Gross T, Mamula P, et al. Hepatosplenic T-cell lymphoma in adolescents and young adults with Crohn's disease: a cautionary tale? Inflamm Bowel Dis. 2007;13:1024-1030.
5. Mackey AC, Green L, Leptak C, et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease: update. J Pediatr Gastroenterol Nutr. 2009;48:386-388.
6. Mackey AC, Green L, Liang LC, et al. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007;44:265-267.
7. Sokol H, Beaugerie L. Inflammatory bowel disease and lymphoproliferative disorders: the dust is starting to settle. Gut. 2009;58:1427-1436.
8. Willot S, Noble A, Deslandres C. Methotrexate in the treatment of inflammatory bowel disease: an 8-year retrospective study in a Canadian pediatric IBD center. Inflamm Bowel Dis. 2011;17:2521-2526.
9. Boyle B, Mackner L, Ross C, et al. A single-center experience with methotrexate after thiopurine therapy in pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2010;51:714-717.
10. Turner D, Grossman AB, Rosh J, et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol. 2007;102:2804-2812; quiz 2803, 2813.
11. Uhlen S, Belbouab R, Narebski K, et al. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis. 2006;12:1053-1057.
12. McDonald JW, Tsoulis DJ, Macdonald JK, et al. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database Syst Rev. 2012;12:CD003459.
13. Stephens MC, Baldassano RN, York A, et al. The bioavailability of oral methotrexate in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2005;40:445-449.
14. Punati J, Markowitz J, Lerer T, et al. Effect of early immunomodulator use in moderate to severe pediatric Crohn disease. Inflamm Bowel Dis. 2008;14:949-954.
15. Riello L, Talbotec C, Garnier-Lengliné H, et al. Tolerance and efficacy of azathioprine in pediatric Crohn's disease. Inflamm Bowel Dis. 2011;17:2138-2143.
16. Panés J, López-Sanromán A, Bermejo F, et al. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease. Gastroenterology. 2013;145:766-774.e761.
17. Cosnes J, Bourrier A, Laharie D, et al. Early administration of azathioprine vs conventional management of Crohn's disease: a randomized controlled trial. Gastroenterology. 2013;145:758-765.e752; quiz e714-e755.
18. Treton X, Bouhnik Y, Mary JY, et al. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse. Clin Gastroenterol Hepatol. 2009;7:80-85.
19. Lémann M, Mary JY, Colombel JF, et al. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine. Gastroenterology. 2005;128:1812-1818.
20. Kandiel A, Fraser AG, Korelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine. Gut. 2005;54:1121-1125.
21. Wolfe F, Michaud K. Lymphoma in rheumatoid arthritis: the effect of methotrexate and anti-tumor necrosis factor therapy in 18, 572 patients. Arthritis Rheum. 2004;50:1740-1751.